Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

229
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
229
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

323
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
323
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

261
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
261
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

397
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
397
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

380
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
380
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

268
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
268

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tricuspid valve repair in infective endocarditis.

Annals of cardiothoracic surgery·2026
Same author

Surgery for hypertrophic obstructive cardiomyopathy: the European perspective.

Indian journal of thoracic and cardiovascular surgery·2026
Same author

Evidence-based guidelines for aortic stenosis: Focus on surgical aortic valve replacement versus transcatheter aortic valve implantation for young patients.

Asian cardiovascular & thoracic annals·2026
Same author

Clinical and Prognostic Differences Between Mechanical Versus Biological Prosthetic Infective Endocarditis-A Nationwide Database Study.

Journal of clinical medicine·2025
Same author

Are outcomes in surgery for infective endocarditis sex-related?

Indian journal of thoracic and cardiovascular surgery·2025
Same author

Transapical Beating-Heart Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy: Lessons Learned After the Learning Curve Period.

Circulation. Cardiovascular interventions·2025
Same journal

Spontaneous Splenic Rupture in Vascular Ehlers-Danlos Syndrome: a Case Report Managed by Coil Embolization of the Splenic Artery.

Portuguese journal of cardiac thoracic and vascular surgery·2026
Same journal

Bilateral Iatrogenic Pneumothorax, Pneumo-mediastinum and Pneumoperitoneum Following Per-oral Endoscopic Myotomy for Achalasia type I: A Case Report.

Portuguese journal of cardiac thoracic and vascular surgery·2026
Same journal

Treatment of Vascular Anomalies With Sirolimus: An Updated Comprehensive Review.

Portuguese journal of cardiac thoracic and vascular surgery·2026
Same journal

Descending Necrotizing Mediastinitis: A 7-Year Single-Centre Experience.

Portuguese journal of cardiac thoracic and vascular surgery·2026
Same journal

A Retrospective Analysis on Level of Suction in Digital Drainage Devices After Video-assisted Lobectomy in a Thoracic Surgery Centre.

Portuguese journal of cardiac thoracic and vascular surgery·2026
Same journal

Traumatic Great Vessel Injuries In Children: A 10-Year Experience Of A Pediatric Intensive Care Unit In A Tertiary Hospital Center.

Portuguese journal of cardiac thoracic and vascular surgery·2026
See all related articles

Related Experiment Video

Updated: Jan 11, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.2K

Managing The Mitral Valve In HCM Surgery: Tips And Tricks.

Sara Ranchordás1, Miguel Abecasis1, Eduard Quintana2

  • 1Cardiac Surgery, Hospital Santa Cruz, ULSLO, Carnaxide, Portugal.

Portuguese Journal of Cardiac Thoracic and Vascular Surgery
|November 13, 2025
PubMed
Summary
This summary is machine-generated.

Mitral regurgitation in hypertrophic cardiomyopathy is often caused by systolic anterior motion (SAM) of the mitral valve (MV). Other structural issues may also contribute, requiring tailored surgical approaches for effective treatment.

Keywords:
Hypertrophic Cardiomyopathymitral regurgitationseptal myectomysystolic anterior motion

More Related Videos

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.3K
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

4.1K

Related Experiment Videos

Last Updated: Jan 11, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.2K
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.3K
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

4.1K

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Echocardiography

Background:

  • Mitral regurgitation (MR) in hypertrophic cardiomyopathy (HCM) patients is primarily attributed to systolic anterior motion (SAM) of the mitral valve (MV).
  • Additional structural abnormalities, including mitral leaflet elongation, papillary muscle anomalies, and mitral-aortic discontinuity, can contribute to MR in HCM.
  • Intraoperative echocardiography is crucial for assessing MV function and regurgitant jets to identify all contributing mechanisms of MR.

Purpose of the Study:

  • To elucidate the diverse mechanisms of mitral regurgitation in hypertrophic cardiomyopathy patients.
  • To highlight the importance of comprehensive echocardiographic evaluation for identifying concomitant causes of MR beyond SAM.
  • To discuss surgical strategies for addressing SAM and associated mitral valve abnormalities in HCM.

Main Methods:

  • Review of echocardiographic findings in HCM patients with mitral regurgitation.
  • Analysis of intraoperative echocardiographic assessments to identify SAM and other structural causes of MR.
  • Evaluation of surgical techniques employed for correction of SAM and mitral valve disease.

Main Results:

  • Systolic anterior motion (SAM) is the predominant cause of MR in HCM, but other factors like leaflet abnormalities and mitral-aortic discontinuity can coexist.
  • Preoperative identification of concomitant MR mechanisms is possible through structural detection or pharmacological provocation.
  • Surgical interventions may include myectomy, mitral valve repair (e.g., AML plasty, papillary muscle reorientation, edge-to-edge repair), or replacement, depending on the specific pathology.

Conclusions:

  • Effective management of MR in HCM requires a thorough understanding of all contributing mechanisms, not solely SAM.
  • Tailored surgical approaches, addressing both SAM and intrinsic mitral valve disease, are essential for optimal outcomes.
  • Postoperative echocardiography, including provocative testing, confirms the elimination of SAM, LVOT obstruction, and resolution of MR.